Sirnaomics, Inc.

Jan 30, 2019

Sirnaomics to Present at 2019 BIO CEO & Investor Conference

Sep 25, 2018

Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team as Chief Technology Officer

Aug 16, 2018

Sirnaomics Oncology IND Receives Green Light from US FDA to Initiate Study for Treatment of Cholangiocarcinoma

Jul 27, 2018

Sirnaomics Appoints Dr. David Evans as Chief Scientific Officer to Lead Preclinical Programs for Novel Antifibrosis and Anticancer RNAi Therapeutics

Jun 06, 2018

Sirnaomics Closed Series C1 Financing of US$25 Million and Expands Clinical Programs of Anti-Fibrosis and Anti-Cancer RNAi Therapeutics

May 03, 2018

Dr. Steven Long Joins Sirnaomics Senior Management Team as Head of China Clinical Studies

Oct 06, 2017

Sirnaomics Publishes Results Showing Dual Targeting of TGF-b1 and COX-2 Reduces Human Skin Hypertrophic Scar through Activation of Fibroblast Apoptosis

Aug 01, 2017

Sirnaomics Leading siRNA Therapeutic Candidate, STP705, Granted Orphan Designation for the Treatment of Primary Sclerosing Cholangitis (PSC)